Poop transplant trial aims to tame harsh cancer drug side effect
NCT ID NCT04038619
Summary
This study is testing if a fecal microbiota transplant (FMT) can safely and effectively treat severe diarrhea and colon inflammation caused by immunotherapy drugs in cancer patients. The treatment involves transferring stool from a healthy donor into the patient's colon during a procedure. Researchers want to see if this can resolve the gut problems and allow patients to potentially continue their cancer therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.